Factors affecting toxicity and efficacy of polymeric nanomedicines
- 15 May 2008
- journal article
- review article
- Published by Elsevier BV in Toxicology and Applied Pharmacology
- Vol. 229 (1), 121-134
- https://doi.org/10.1016/j.taap.2008.02.007
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Predictive Factors of Oxaliplatin Neurotoxicity: The Involvement of the Oxalate Outcome PathwayClinical Cancer Research, 2007
- Optimization of (1,2-diamino-cyclohexane)platinum(II)-loaded polymeric micelles directed to improved tumor targeting and enhanced antitumor activityJournal of Controlled Release, 2007
- NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxelBritish Journal of Cancer, 2005
- Preparation and biological properties of dichloro(1,2-diaminocyclohexane)platinum(II) (DACHPt)-loaded polymeric micellesJournal of Controlled Release, 2005
- Preparation and Biological Characterization of Polymeric Micelle Drug Carriers with Intracellular pH-Triggered Drug Release Property: Tumor Permeability, Controlled Subcellular Drug Distribution, and Enhanced in Vivo Antitumor EfficacyBioconjugate Chemistry, 2004
- Hepatic uptake of negatively charged particles in rats: possible involvement of serum proteins in recognition by scavenger receptorJournal of Controlled Release, 2004
- Angiogenesis in cancer and other diseasesNature, 2000
- Nonclinical safety evaluation of biotechnologically derived pharmaceuticalsBiotechnology Annual Review, 2000
- Functional Morphology of the ThyroidInternational Review of Cytology, 1988
- A Scanning Electron Microscope Study of the Human SpleenArchivum histologicum japonicum, 1974